Condition
Chronic Myeloid Leukemia in Myeloid Blast Crisis
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (2)
Trial Status
Unknown3
Suspended1
Clinical Trials (4)
Showing 4 of 4 trials
NCT05322850Phase 1Suspended
Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)
NCT03869502UnknownPrimary
European CML Blast Crisis Register
NCT05376852Phase 2UnknownPrimary
Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML
NCT01690065Phase 2UnknownPrimary
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML
Showing all 4 trials